Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Venous Thromboembolism: drug therapy"'
Autor:
Bradbury, Charlotte A., Lawler, Patrick R., Stanworth, Simon J., McVerry, Bryan J., McQuilten, Zoe, Higgins, Alisa M., Mouncey, Paul R., Al-Beidh, Farah, Rowan, Kathryn M., Berry, Lindsay R., Lorenzi, Elizabeth, Zarychanski, Ryan, Arabi, Yaseen M., Annane, Djillali, Beane, Abi, Van Bentum-Puijk, Wilma, Bhimani, Zahra, Bihari, Shailesh, Bonten, Marc J. M., Brunkhorst, Frank M., Buzgau, Adrian, Buxton, Meredith, Carrier, Marc, Cheng, Allen C., Cove, Matthew, Detry, Michelle A., Estcourt, Lise J., Fitzgerald, Mark, Girard, Timothy D., Goligher, Ewan C., Goossens, Herman, Haniffa, Rashan, Hills, Thomas, Huang, David T., Horvat, Christopher M., Hunt, Beverley J., Ichihara, Nao, Lamontagne, Francois, Leavis, Helen L., Linstrum, Kelsey M., Litton, Edward, Marshall, John C., McAuley, Daniel F., McGlothlin, Anna, McGuinness, Shay P., Middeldorp, Saskia, Montgomery, Stephanie K., Morpeth, Susan C., Murthy, Srinivas, Neal, Matthew D., Nichol, Alistair D., Parke, Rachael L., Parker, Jane C., Reyes, Luis, Saito, Hiroki, Santos, Marlene S., Saunders, Christina T., Serpa-Neto, Ary, Seymour, Christopher W., Shankar-Hari, Manu, Singh, Vanessa, Tolppa, Timo, Turgeon, Alexis F., Turner, Anne M., van de Veerdonk, Frank L., Green, Cameron, Lewis, Roger J., Angus, Derek C., McArthur, Colin J., Berry, Scott, Derde, Lennie P. G., Webb, Steve A., Gordon, Anthony C., Depuydt, Pieter, De Waele, Jan, De Bus, Liesbet, Fierens, Jan, Vermassen, Joris
Publikováno v:
Jama : Journal of the American Medical Association, 327, 1247-1259
JAMA : the journal of the American Medical Association
Journal of the American Medical Association
Journal of the American Medical Association, 2022, 327 (13), pp.1247-1259. ⟨10.1001/jama.2022.2910⟩
2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 : A Randomized Clinical Trial ', JAMA-Journal of the American Medical Association, vol. 327, no. 13, 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Jama : Journal of the American Medical Association, 327, 13, pp. 1247-1259
2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 : A Randomized Clinical Trial ', Journal of the American Medical Association, vol. 327, no. 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
Investigators, REMAP-CAP W C F T REMAP-CAP & Dark, P 2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. ', JAMA, vol. 327, no. 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
JAMA-Journal of the American Medical Association, 327(13), 1247-1259. American Medical Association
JAMA : the journal of the American Medical Association
Journal of the American Medical Association
Journal of the American Medical Association, 2022, 327 (13), pp.1247-1259. ⟨10.1001/jama.2022.2910⟩
2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 : A Randomized Clinical Trial ', JAMA-Journal of the American Medical Association, vol. 327, no. 13, 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Jama : Journal of the American Medical Association, 327, 13, pp. 1247-1259
2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 : A Randomized Clinical Trial ', Journal of the American Medical Association, vol. 327, no. 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
Investigators, REMAP-CAP W C F T REMAP-CAP & Dark, P 2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. ', JAMA, vol. 327, no. 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
JAMA-Journal of the American Medical Association, 327(13), 1247-1259. American Medical Association
Contains fulltext : 248713.pdf (Publisher’s version ) (Closed access) IMPORTANCE: The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is uncertain. OBJECTIVE: To determine whether antiplatelet therapy improves outcomes for
Autor:
Petra Bistrovic, Anica Sabljic, Ivona Kovacevic, Tomislav Cikara, Tatjana Keres, Tomo Lucijanic, Josko Mitrovic, Diana Delic-Brkljacic, Sime Manola, Marko Lucijanic
Introduction: There are conflicting data on prior oral-anticoagulant (OAC) use and outcomes of hospitalized COVID-19 patients. Due to uncertainties regarding associated risks with the prior OAC use, we have investigated this issue in a large cohort o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b438a24431e8fa1d030b453774d4df6
https://doi.org/10.1016/j.ijcard.2022.11.051
https://doi.org/10.1016/j.ijcard.2022.11.051
Autor:
Ingrid M. Bistervels, Hanke M.G. Wiegers, Fionnuala Ní Áinle, Suzanne M. Bleker, Céline Chauleur, Jennifer Donnelly, Anne F. Jacobsen, Marc A. Rodger, Maria T. DeSancho, Peter Verhamme, Anette T. Hansen, Roman G. Shmakov, Wessel Ganzevoort, Andrea Buchmüller, Saskia Middeldorp
Publikováno v:
Journal of Thrombosis and Haemostasis, 21, 57-67
Bistervels, I M, Wiegers, H M G, Áinle, F N, Bleker, S M, Chauleur, C, Donnelly, J, Jacobsen, A F, Rodger, M A, DeSancho, M T, Verhamme, P, Hansen, A T, Shmakov, R G, Ganzevoort, W, Buchmüller, A, Middeldorp, S & Highlow Investigators 2023, ' Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin : insights from the Highlow study ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 57-67 . https://doi.org/10.1016/j.jtha.2022.11.004
Journal of Thrombosis and Haemostasis, 21, 1, pp. 57-67
Journal of thrombosis and haemostasis : JTH, 21(1), 57-67. Wiley-Blackwell
Bistervels, I M, Wiegers, H M G, Áinle, F N, Bleker, S M, Chauleur, C, Donnelly, J, Jacobsen, A F, Rodger, M A, DeSancho, M T, Verhamme, P, Hansen, A T, Shmakov, R G, Ganzevoort, W, Buchmüller, A, Middeldorp, S & Highlow Investigators 2023, ' Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin : insights from the Highlow study ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 57-67 . https://doi.org/10.1016/j.jtha.2022.11.004
Journal of Thrombosis and Haemostasis, 21, 1, pp. 57-67
Journal of thrombosis and haemostasis : JTH, 21(1), 57-67. Wiley-Blackwell
Item does not contain fulltext BACKGROUND: Peripartum management of women using low-molecular-weight heparin (LMWH) varies widely. Minimum time intervals are required between LMWH injection and neuraxial procedure, and they differ by dose. OBJECTIVES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3654d189dac1bc9406534275cd70541
http://hdl.handle.net/2066/290874
http://hdl.handle.net/2066/290874
Autor:
Ingrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, Fionnuala Ní Áinle, Bernard Tardy, Jennifer Donnelly, Peter Verhamme, Anne F Jacobsen, Anette T Hansen, Marc A Rodger, Maria T DeSancho, Roman G Shmakov, Nick van Es, Martin H Prins, Céline Chauleur, Saskia Middeldorp, Eline S van den Akker, Mireille N Bekker, Thomas van Bemmel, Laurent Bertoletti, Julie Blanc, Suzanne M Bleker, Aude Bourtembourg-Matras, Florence Bretelle, Bridgette Byrne, Francis Couturaud, Pierre Delorme, Elise S Eerenberg, Maureen TM Franssen, Jens Fuglsang, Wessel Ganzevoort, François Goffinet, Jiska M de Haan-Jebbink, Wieteke Heidema, Monique A Hertzberg, Marcel MC Hovens, Menno V Huisman, Leonie de Jong-Speksnijder, Pieter-Willem Kamphuisen, Denis J O'Keeffe, Karine Lacut, Josje Langenveld, M Simone Lunshof, Caroline P Martens, Adel Merah, Emmanuelle Le Moigne, Dimitri NM Papatsonis, Gilles Pernod, Franck Perrotin, Edith Peynaud-Debayle, Fabrice Pierre, Geneviève Plu Bureau, Tiphaine Raia-Barjat, Robbert JP Rijnders, Roger Rosario, Marc Ruivard, Jeannot Schmidt, Marieke Sueters, Thomas Vanassche, Marie-Noëlle Varlet, Alexandre J Vivanti, Matthieu Y van der Vlist, Lucet F van der Voet, Karlijn C Vollebregt, Johanna IP de Vries, Sabina de Weerd, Peter E Westerweel, Lia DE Wijnberger, Marije ten Wolde, Paula F Ypma, Catherine Zuily-Lamy, Joost J Zwart, Alexandra Benachi, Gaël Beucher, Holy Bezanahary, Karin de Boer, Marjon A. de Boer, Frantz Bousquet, Henk A. Bremer, Luc Bressollette, Aurélie Brossard, Cécile Chau, Brian Cleary, Fabienne Comte, Thomas Corsini, Anne Coustel, Barbara Debaveye, Raoul Desbrière, Cécile Duvillard, Astrid Eckman, Jeroen Eikenboom, Antoine Elias, Laura M. Faber, Emile Ferrari, Denis Gallot, Emilie Gauchotte, Ingrid Gaugler, Abby E. Geerlings, Audrey O'Gorman, Vincent Grobost, Pieter-Kees de Groot, David P. van der Ham, Brenda Hermsen, Kim Kamphorst, Alan Karovitch, Gunilla Kleiverda, Aiste Kloster, Annemarieke Koops, Inneke Krabbendam, Marieke J.H.A. Kruip, Saskia Kuipers, Judith van Laar, Damien Laneelle, Suzanne Lima, Peter MacMahon, Laurent Mandelbrot, Claudia A. van Meir, Caroline Menez, Leonard P. Morssink, Nathalie Moulin, Eve Mousty, Matthieu Muller, Lucy Murphy, Kathelijne Peerlinck, Alma O'Reilly, Maartje de Reus, Magali Hilmi Le Roux, Kevin Ryan, Bettina Samren, Daniela Schippers, Nico Schuitemaker, Chloé Schweizer, Hanneke van der Straaten, Cécile Tromeur, Kristine Vanheule, Tamara Verhagen, Jantien Visser, Michael Watts, Wim J. van Wijngaarden, Mallory Woiski, Maartje Zelis
Publikováno v:
The Lancet, 400(10365), 1777-1787. Elsevier Limited
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Item does not contain fulltext BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8643920b0d7863c0bf84cfcc765abbb7
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9
Autor:
Winckers, Kristien, Ten Cate, Hugo
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 166:D6882. Bohn Stafleu van Loghum
Hospitalization and surgery are associated with an increased risk of deep vein thrombosis and pulmonary embolism. Low molecular weight heparins (LMWH) are effective in venous thromboembolism (VTE) prevention and have been the treatment of choice duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::ad2279662cd4335f010ab4e309e276f9
https://cris.maastrichtuniversity.nl/en/publications/791089d0-63f4-4aed-bc9f-6c36dd1e4c69
https://cris.maastrichtuniversity.nl/en/publications/791089d0-63f4-4aed-bc9f-6c36dd1e4c69
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde. 166
Hospitalization and surgery are associated with an increased risk of deep vein thrombosis and pulmonary embolism. Low molecular weight heparins (LMWH) are effective in venous thromboembolism (VTE) prevention and have been the treatment of choice duri
Autor:
Ruben J Eck, Tessa Elling, Alex J Sutton, Jørn Wetterslev, Christian Gluud, Iwan C C van der Horst, Reinold O B Gans, Karina Meijer, Frederik Keus
Publikováno v:
BMJ (Clinical research ed.), 378. BMJ PUBLISHING GROUP
ObjectiveTo assess the benefits and harms of different types and doses of anticoagulant drugs for the prevention of venous thromboembolism in patients who are acutely ill and admitted to hospital.DesignSystematic review and network meta-analysis.Data
Publikováno v:
Revue medicale suisse, vol. 18, no. 783, pp. 1057-1063
Thromboembolic complications in adults with congenital heart disease are frequent and responsible for significant morbidity and mortality. Their prevention frequently requires long-term thromboprophylaxis. In this article, we discuss the specificitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::6160baf170dfb32ed657b02c26736578
https://serval.unil.ch/resource/serval:BIB_1224D3719DB2.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_1224D3719DB2.P001/REF.pdf
Publikováno v:
Kotalczyk, A, Guo, Y, Stefil, M, Wang, Y, Lip, G Y H & on behalf of the ChiOTEAF Registry Investigators 2022, ' Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy : A Report From the ChiOTEAF Registry ', Journal of the American Heart Association, vol. 11, no. 7, e024319 . https://doi.org/10.1161/JAHA.121.024319
Background Patients with atrial fibrillation commonly have complex clinical backgrounds of multimorbidity and polypharmacy. The Atrial Fibrillation Better Care (ABC) pathway has been developed to help deliver integrated and holistic care for patients
Autor:
Kathrine Parker, John Hartemink, Ananya Saha, Roshni Mitra, Penny Lewis, Albert Power, Satarupa Choudhuri, Sandip Mitra, Jecko Thachil
Publikováno v:
Parker, K, Hartemink, J, Saha, A, Mitra, R, Lewis, P, Power, A, Choudhuri, S, Mitra, S & Thachil, J 2022, ' A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease ', Journal of Nephrology . https://doi.org/10.1007/s40620-022-01413-x
Parker, K, Hartemink, J, Saha, A, Mitra, R, Lewis, P, Power, A, Choudhuri, S, Mitra, S & Thachil, J 2022, ' A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease ', Journal of Nephrology, vol. 35, no. 8, pp. 2015-2033 . https://doi.org/10.1007/s40620-022-01413-x
Parker, K, Hartemink, J, Saha, A, Mitra, R, Lewis, P, Power, A, Choudhuri, S, Mitra, S & Thachil, J 2022, ' A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease ', Journal of Nephrology, vol. 35, no. 8, pp. 2015-2033 . https://doi.org/10.1007/s40620-022-01413-x
BackgroundPatients with chronic kidney disease (CKD) have an increased risk of venous thromboembolism (VTE) and atrial fibrillation (AF). Anticoagulants have not been studied in randomised controlled trials with CrCl MethodsWe conducted a systematic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904cfee5ca9e03a8e242c35bdc9dc982
http://www.scopus.com/inward/record.url?scp=85137019706&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85137019706&partnerID=8YFLogxK